Target-based Classification of Drugs

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level 

     Type
 G Protein-coupled receptors
 
 Ion channels
 
 Nuclear receptors
 
 Protein kinases
 
 Cytokines and receptors
 
 Cell surface molecules and ligands
 
 Transporters
   ABC transporters
   Solute carrier family
     SLC5
       SLC5A1 (SGLT1) [HSA:6523] [KO:K14158]
       SLC5A2 (SGLT2) [HSA:6524] [KO:K14382]
         D08897  Dapagliflozin (USAN/INN)
         D09763  Dapagliflozin propanediol (USAN) <JP/US>
         D09592  Canagliflozin (USAN/INN) <JP/US>
         D10459  Empagliflozin (JAN/USAN/INN) <JP/US>
         D10313  Ertugliflozin (USAN/INN)
         D11043  Ertugliflozin pidolate <US>
         D10196  Ipragliflozin (INN) <US>
         D10200  Ipragliflozin L-proline (JAN) <JP>
         D10669  Sotagliflozin (USAN/INN)
         D06641  Sergliflozin etabonate (USAN)
         D09978  Tofogliflozin (USAN) <JP>
         D10055  Remogliflozin etabonate (USAN/INN)
         D10195  Luseogliflozin hydrate (JAN) <JP>
         D10865  Bexagliflozin (USAN)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     SLC6
     SLC9
     SLC10
     SLC12
     SLC18
     SLC22
     SLC29
     SLC34
   Major facilitator superfamily
   Other transporters
 
 Enzymes
 
 Nucleic acids
 
 Not elsewhere classified

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: April 9, 2020

» Japanese version